Merck files quarterly report (10-Q) for the period ended Jun 30, 2026
Merck filed its quarterly report on Form 10-Q with the SEC on Aug 7, 2026, 4:11 PM ET, covering the quarter ended Jun 30, 2026. It reports fiscal Q2 2026 results.
- Revenue: $16.61B (+5.1% from $15.81B a year earlier)
- Net income: −$1.33B (vs $4.43B a year earlier)
- Diluted EPS: $-0.54 (vs $1.76 a year earlier)
- Form 10-Q accepted by EDGAR Aug 7, 2026, 4:11 PM ET
- Accession number 0000310158-26-000212
Source
SEC EDGARAug 7, 2026, 4:11 PM ET
SEC filing 10-Q · accession 0000310158-26-000212 · sec.gov ↗